MLAB — Mesa Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $632.91m
- $797.67m
- $216.19m
- 69
- 21
- 43
- 41
Annual cashflow statement for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.78 | 3.27 | 1.87 | 0.93 | -254 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 17.3 | 14.4 | 19.3 | 13.8 | 289 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.14 | 5.25 | -7.19 | -17.1 | 5.97 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 27 | 37.1 | 39.2 | 28 | 44.1 |
| Capital Expenditures | -1.5 | -1.99 | -4.43 | -4.54 | -2.57 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -184 | 0 | -301 | -4.95 | -78.7 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -186 | -1.99 | -305 | -9.49 | -81.3 |
| Financing Cash Flow Items | -5.44 | -0.968 | -0.237 | -0.919 | -1.57 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 231 | 146 | 52.6 | -33.3 | 32.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 71.2 | 182 | -215 | -16.4 | -4.7 |